Sentiment-Signal
19,0
Stark Bearisch
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
0
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)
Score-Verlauf (90 Tage)
Stammdaten
Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
Unternehmen & Branche
| Name | Schrodinger, Inc. |
|---|---|
| Ticker | SDGR |
| CIK | 0001490978 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Healthcare Information Services |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 901,4 Mio. USD |
| Beta | 1,62 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 255,869,000 | -103,265,000 | -1.41 | 726,160,000 | 364,053,000 |
| 2025-09-30 | 10-Q | 54,324,000 | -32,795,000 | -0.45 | 653,660,000 | 321,352,000 |
| 2025-06-30 | 10-Q | 54,759,000 | -43,173,000 | -0.59 | 688,244,000 | 342,872,000 |
| 2025-03-31 | 10-Q | 59,551,000 | -59,808,000 | -0.82 | 743,032,000 | 373,504,000 |
| 2024-12-31 | 10-K | 207,539,000 | -187,123,000 | -2.57 | 823,226,000 | 421,445,000 |
| 2024-09-30 | 10-Q | 35,290,000 | -38,136,000 | -0.52 | 669,296,000 | 449,425,000 |
| 2024-06-30 | 10-Q | 47,334,000 | -54,047,000 | -0.74 | 688,371,000 | 473,980,000 |
| 2024-03-31 | 10-Q | 36,598,000 | -54,724,000 | -0.76 | 737,762,000 | 513,706,000 |
| 2023-12-31 | 10-K | 216,666,000 | 40,720,000 | 0.54 | 802,955,000 | 548,558,000 |
| 2023-09-30 | 10-Q | 42,569,000 | -62,024,000 | -0.86 | 794,148,000 | 563,581,000 |
| 2023-06-30 | 10-Q | 35,189,000 | 4,278,000 | 0.06 | 841,566,000 | 611,225,000 |
| 2023-03-31 | 10-Q | 64,782,000 | 129,136,000 | 1.75 | 838,773,000 | 590,260,000 |
| 2022-12-31 | 10-K | 180,955,000 | -149,186,000 | -2.10 | 688,587,000 | 447,894,000 |
| 2022-09-30 | 10-Q | 36,980,000 | -39,853,000 | -0.56 | 661,985,000 | 463,110,000 |
| 2022-06-30 | 10-Q | 38,469,000 | -47,686,000 | -0.67 | 687,880,000 | 493,058,000 |
| 2022-03-31 | 10-Q | 48,663,000 | -34,440,000 | -0.48 | 719,537,000 | 530,667,000 |
| 2021-12-31 | 10-K | 137,931,000 | -100,393,000 | -1.42 | 756,487,000 | 557,071,000 |
| 2021-09-30 | 10-Q | 29,850,000 | -35,007,000 | -0.49 | 762,617,000 | 579,806,000 |
| 2021-06-30 | 10-Q | 29,784,000 | -34,644,000 | -0.49 | 717,334,000 | 605,751,000 |
| 2021-03-31 | 10-Q | 32,127,000 | -29,000 | 744,189,000 | 631,768,000 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-04-17 | Farid Ramy | Director, Officer, President & CEO | Open Market Sale | -43,000 | 12.21 | -524,944.00 | -680,5% | |
| 2026-04-16 | Farid Ramy | Director, Officer, President & CEO | Open Market Sale | -43,000 | 12.33 | -530,233.00 | -687,4% | |
| 2026-04-16 | Jain Rachit | Officer, EVP & CFO | Open Market Sale | -844 | 12.75 | -10,758.47 | -13,9% | |
| 2026-03-06 | Herman Jenny | Officer, CAO | Open Market Sale | -608 | 12.84 | -7,807.94 | -10,1% | |
| 2026-03-05 | Tran Yvonne | Officer, EVP, CLO & CPO | Open Market Sale | -1,094 | 12.90 | -14,107.13 | -18,3% | |
| 2026-03-05 | Herman Jenny | Officer, CAO | Open Market Sale | -775 | 12.85 | -9,955.65 | -12,9% | |
| 2026-03-05 | Akinsanya Karen | Officer, See Remarks | Open Market Sale | -1,366 | 12.90 | -17,625.50 | -22,8% | |
| 2026-03-05 | Lorton Kenneth Patrick | Officer, EVP, CTO & COO, Software | Open Market Sale | -1,222 | 12.90 | -15,761.36 | -20,4% | |
| 2026-03-05 | Farid Ramy | Director, Officer, President & CEO | Open Market Sale | -3,661 | 12.91 | -47,248.87 | -61,3% | |
| 2026-03-05 | Jain Rachit | Officer, EVP & CFO | Open Market Sale | -1,631 | 12.90 | -21,033.38 | -27,3% | |
| 2026-03-04 | Abel Robert Lorne | Officer, See Remarks | Open Market Sale | -1,300 | 12.81 | -16,653.00 | -21,6% | |
| 2026-03-02 | Akinsanya Karen | Officer, See Remarks | Open Market Sale | -2,206 | 11.99 | -26,454.35 | -34,3% | |
| 2026-03-02 | Farid Ramy | Director, Officer, President & CEO | Open Market Sale | -5,560 | 11.90 | -66,151.21 | -85,8% | |
| 2026-02-10 | Herman Jenny | Officer, CAO | Open Market Sale | -752 | 13.79 | -10,370.38 | -13,4% | |
| 2026-02-10 | Lorton Kenneth Patrick | Officer, EVP, CTO & COO, Software | Open Market Sale | -925 | 13.73 | -12,703.77 | -16,5% | |
| 2026-02-10 | Tran Yvonne | Officer, EVP, CLO & CPO | Open Market Sale | -776 | 13.80 | -10,705.39 | -13,9% | |
| 2026-02-09 | Abel Robert Lorne | Officer, See Remarks | Open Market Sale | -1,230 | 13.51 | -16,617.30 | -21,5% | |
| 2025-10-16 | Dugan Margaret | Officer, Chief Medical Officer | Open Market Sale | -1,395 | 21.07 | -29,387.07 | -38,1% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.